November 7, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Avalere Health, Barack Obama, Caroline Pearson, Department of Health and Human Services, Donald Trump, health insurance exchange, HealthCare.gov, Hillary Clinton, Kaiser Family Foundation, Larry Levitt, Obamacare, Orrin Hatch, Sylvia Burwell
2016, Issue 11-07-2016, Issues, News

WASHINGTON — Premiums for health plans purchased through the Affordable Care Act will rise sharply next year, and insurer defections in some states will leave consumers with substantially fewer coverage options, the federal government reported. Premiums will increase, on average, 25% for mid-level plans on the federal health insurance exchange, according to the Department of
October 19, 2016 by Geoff Walden and Chain Drug Review
2016 presidential election, ACA, Affordable Care Act, Donald Trump, health care, health insurance, Hillary Clinton, Obamacare
Featured Articles, Issue 10-24-2016, Leading Headlines, News, Pharmacy, Retail News

WASHINGTON — Change is apparently looming for the Affordable Care Act, regardless of whether Hillary Clinton or Donald Trump wins the 2016 presidential election. Though it’s uncertain if health care will emerge as a topic at tonight’s third and final presidential debate in Las Vegas at the University of Nevada, the issue was the subject
September 26, 2016 by Greg Jacobson and Chain Drug Review
2016 presidential election, Affordable Care Act, Donald Trump, drug pricing, generic drugs, health care, Hillary Clinton, prescription drug costs
2016, Business, Issue 09-26-2016, Issues, Leading Headlines, News, Retail News

NEW YORK — With the 2016 presidential election drawing near, health care has emerged as a policy area in which the two major candidates’ differences are strikingly clear. A useful starting point might be their respective approaches to prescription drug pricing. The Republican candidate, Donald Trump, created a sensation in January when he advocated allowing
September 26, 2016 by Jeffrey Woldt and Chain Drug Review
2016 presidential election campaign, Affordable Care Act, Donald Trump, HealthCare.gov, Hillary Clinton, Jeffrey Woldt
2016, Issue 09-26-2016, Issues, Opinion

One of the more surprising aspects of the sad spectacle leading up to the election of a new president and new Congress in November is the lack of serious, sustained debate about health care. When the Patient Protection and Affordable Care Act was signed into law by President Obama in March 2010, the nation embarked
October 12, 2015 by Jeffrey Woldt and Chain Drug Review
2016 presidential race, Affordable Care Act, Bernie Sanders, cost of prescription drugs, Daraprim, Harvoni, Hillary Clinton, Jeffrey Woldt, pharmaceutical prices, Sovaldi, Viekira Pak
2015, Issue 10-12-2015, Issues, Opinion

The 2016 presidential race is already well under way. Despite thousands of speeches, interviews and, on the Republican side, two debates, there is a lot about the candidates’ thinking that needs to be clarified. One thing, however, is certain — health care will be a prominent issue as the process of choosing Barack Obama’s successor